Hypertrophic cardiomyopathy: Two homozygous cases with "typical" hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy

Luisa Nanni, Maurizio Pieroni, Cristina Chimenti, Barbara Simionati, Rosanna Zimbello, Attilio Maseri, Andrea Frustaci, Gerolamo Lanfranchi

Research output: Contribution to journalArticle

Abstract

About 10% of cases of hypertrophic cardiomyopathy (HCM) evolve into dilated cardiomyopathy (DCM) with unknown causes. We studied 11 unrelated patients (pts) with HCM who progressed to DCM (group A) and 11 who showed "typical" HCM (group B). Mutational analysis of the β-myosin heavy chain (MYH7), myosin-binding protein C (MYBPC3), and cardiac troponin T (TNNT2) genes demonstrated eight mutations affecting MYH7 or MYBPC3 gene, five of which were new mutations. In group A-pts, the first new mutation occurred in the myosin head-rod junction and the second occurred in the light chain-binding site. The third new mutation leads to a MYBPC3 lacking titin and myosin binding sites. In group B, two pts with severe HCM carried two homozygous MYBPC3 mutations and one with moderate hypertrophy was a compound heterozygous for MYBPC3 gene. We identified five unreported mutations, potentially "malignant" defects as for the associated phenotypes, but no specific mutations of HCM/DCM.

Original languageEnglish
Pages (from-to)391-398
Number of pages8
JournalBiochemical and Biophysical Research Communications
Volume309
Issue number2
DOIs
Publication statusPublished - Sep 19 2003

Fingerprint

Hypertrophic Cardiomyopathy
Dilated Cardiomyopathy
Genes
Myosins
Mutation
Binding Sites
Connectin
Troponin T
Myosin Heavy Chains
Defects
Myosin Subfragments
Hypertrophy
Head
Phenotype
Light

Keywords

  • Compound heterozygous
  • Dilated cardiomyopathy
  • Homozygous mutation
  • Hypertrophic cardiomyopathy
  • Mutation detection
  • Myosin heavy chain 7
  • Myosin-binding protein C
  • Troponin T2

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Hypertrophic cardiomyopathy : Two homozygous cases with "typical" hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy. / Nanni, Luisa; Pieroni, Maurizio; Chimenti, Cristina; Simionati, Barbara; Zimbello, Rosanna; Maseri, Attilio; Frustaci, Andrea; Lanfranchi, Gerolamo.

In: Biochemical and Biophysical Research Communications, Vol. 309, No. 2, 19.09.2003, p. 391-398.

Research output: Contribution to journalArticle

@article{8afae3ee555b42459ca2988c661ea413,
title = "Hypertrophic cardiomyopathy: Two homozygous cases with {"}typical{"} hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy",
abstract = "About 10{\%} of cases of hypertrophic cardiomyopathy (HCM) evolve into dilated cardiomyopathy (DCM) with unknown causes. We studied 11 unrelated patients (pts) with HCM who progressed to DCM (group A) and 11 who showed {"}typical{"} HCM (group B). Mutational analysis of the β-myosin heavy chain (MYH7), myosin-binding protein C (MYBPC3), and cardiac troponin T (TNNT2) genes demonstrated eight mutations affecting MYH7 or MYBPC3 gene, five of which were new mutations. In group A-pts, the first new mutation occurred in the myosin head-rod junction and the second occurred in the light chain-binding site. The third new mutation leads to a MYBPC3 lacking titin and myosin binding sites. In group B, two pts with severe HCM carried two homozygous MYBPC3 mutations and one with moderate hypertrophy was a compound heterozygous for MYBPC3 gene. We identified five unreported mutations, potentially {"}malignant{"} defects as for the associated phenotypes, but no specific mutations of HCM/DCM.",
keywords = "Compound heterozygous, Dilated cardiomyopathy, Homozygous mutation, Hypertrophic cardiomyopathy, Mutation detection, Myosin heavy chain 7, Myosin-binding protein C, Troponin T2",
author = "Luisa Nanni and Maurizio Pieroni and Cristina Chimenti and Barbara Simionati and Rosanna Zimbello and Attilio Maseri and Andrea Frustaci and Gerolamo Lanfranchi",
year = "2003",
month = "9",
day = "19",
doi = "10.1016/j.bbrc.2003.08.014",
language = "English",
volume = "309",
pages = "391--398",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Hypertrophic cardiomyopathy

T2 - Two homozygous cases with "typical" hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy

AU - Nanni, Luisa

AU - Pieroni, Maurizio

AU - Chimenti, Cristina

AU - Simionati, Barbara

AU - Zimbello, Rosanna

AU - Maseri, Attilio

AU - Frustaci, Andrea

AU - Lanfranchi, Gerolamo

PY - 2003/9/19

Y1 - 2003/9/19

N2 - About 10% of cases of hypertrophic cardiomyopathy (HCM) evolve into dilated cardiomyopathy (DCM) with unknown causes. We studied 11 unrelated patients (pts) with HCM who progressed to DCM (group A) and 11 who showed "typical" HCM (group B). Mutational analysis of the β-myosin heavy chain (MYH7), myosin-binding protein C (MYBPC3), and cardiac troponin T (TNNT2) genes demonstrated eight mutations affecting MYH7 or MYBPC3 gene, five of which were new mutations. In group A-pts, the first new mutation occurred in the myosin head-rod junction and the second occurred in the light chain-binding site. The third new mutation leads to a MYBPC3 lacking titin and myosin binding sites. In group B, two pts with severe HCM carried two homozygous MYBPC3 mutations and one with moderate hypertrophy was a compound heterozygous for MYBPC3 gene. We identified five unreported mutations, potentially "malignant" defects as for the associated phenotypes, but no specific mutations of HCM/DCM.

AB - About 10% of cases of hypertrophic cardiomyopathy (HCM) evolve into dilated cardiomyopathy (DCM) with unknown causes. We studied 11 unrelated patients (pts) with HCM who progressed to DCM (group A) and 11 who showed "typical" HCM (group B). Mutational analysis of the β-myosin heavy chain (MYH7), myosin-binding protein C (MYBPC3), and cardiac troponin T (TNNT2) genes demonstrated eight mutations affecting MYH7 or MYBPC3 gene, five of which were new mutations. In group A-pts, the first new mutation occurred in the myosin head-rod junction and the second occurred in the light chain-binding site. The third new mutation leads to a MYBPC3 lacking titin and myosin binding sites. In group B, two pts with severe HCM carried two homozygous MYBPC3 mutations and one with moderate hypertrophy was a compound heterozygous for MYBPC3 gene. We identified five unreported mutations, potentially "malignant" defects as for the associated phenotypes, but no specific mutations of HCM/DCM.

KW - Compound heterozygous

KW - Dilated cardiomyopathy

KW - Homozygous mutation

KW - Hypertrophic cardiomyopathy

KW - Mutation detection

KW - Myosin heavy chain 7

KW - Myosin-binding protein C

KW - Troponin T2

UR - http://www.scopus.com/inward/record.url?scp=0041923834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041923834&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2003.08.014

DO - 10.1016/j.bbrc.2003.08.014

M3 - Article

C2 - 12951062

AN - SCOPUS:0041923834

VL - 309

SP - 391

EP - 398

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -